Why Snap Inc. Stock Is Setting A New Streak Higher

Snap Inc. (NASDAQ: SNAP) shares are trading higher Monday after The Verge reported the company's internal goals for 2024.

Snap Inc. (NASDAQ:SNAP) shares are trading higher Monday after The Verge reported the company’s internal goals for 2024.

The Details:

The Verge reported details of an internal company letter from Snap CEO Evan Spiegel to employees outlining the company’s goals for 2024.  

Here are the figures listed as Snap’s internal goals for 2024:

“Grow Community and Engagement

  • 475+ Million Daily Active Users in Q4 ’24
  • Grow Content Viewers to 80% of DAU
  • Grow Content View Time per Viewer +15% in the US and Globally

Grow Revenue and Earnings

  • +20% YoY Full Year Ads Revenue Growth 
  • 14 Million Snapchat+ Subscribers by EoY and $500 million in non-Ads Revenue
  • $500 million of Adj. EBITDA and Positive Free Cash Flow

Lead in Augmented Reality

  • Grow Lens Unique Users to 75% of DAU 
  • Grow Lens Actions (Save, Post, Send, or Play >6s) +10% per User
  • Leverage Generative AI to Transform Lenses and Content Creation”

Snap Inc. is set to report its third-quarter financial results after the market close on Oct. 24. According to estimates from Benzinga Pro, Snap Inc. is expected to report losses of 4 cents per share and quarterly revenue of $1.11 billion. 

Related News: What’s Going On With Bitcoin Whale MicroStrategy Stock?

SNAP Price Action: According to Benzinga Pro, Snap Inc. shares are up 11% at $9.65 at the time of publication.

Image: MrJayW from Pixabay

Total
0
Shares
Related Posts
Read More

Ionis Pharmaceuticals, Inc. Announces The Journal Of The American Medical Association Published Results From The Phase 3 NEURO-TTRansform Study Of Eplontersen, An Investigational Treatment For Hereditary Transthyretin-Mediated Amyloid Polyneuropathy

Publication of NEURO-TTRansform study in patients with hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN) showed eplontersen halted disease progression and continuously improved quality of life at 35-,

IONS